Several studies have reported that TXNIP overexpression induces apoptosis in pancreatic β-cells [17, 44] and TXNIP-mediated cardiomyocyte apoptosis is highly involved in the pathogenesis of diabetic cardiomyopathy [45]. Here, TXNIP is linked to diabetic cardiomyopathy.